Palliative Management of Advanced Peritoneal Carcinomatosis

Laura A Lambert; Ryan J Hendrix

doi:10.1016/j.soc.2018.02.008

Palliative Management of Advanced Peritoneal Carcinomatosis

Surg Oncol Clin N Am. 2018 Jul;27(3):585-602. doi: 10.1016/j.soc.2018.02.008.

Authors

Laura A Lambert¹, Ryan J Hendrix²

Affiliations

¹ Surgical Oncology, Huntsman Cancer Institute, 2000 Circle of Hope Drive, Salt Lake City, UT 84112, USA. Electronic address: laura.lambert@hci.utah.edu.
² Division of Surgical Oncology, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue N., Worcester, MA 01608, USA.

PMID: 29935691
DOI: 10.1016/j.soc.2018.02.008

Abstract

Despite advances in the management of peritoneal carcinomatosis, morbidity remains high with survival often measured in weeks to months. Patients are often subjected to symptoms and complications that impact quality of life. Much of the management revolves around palliation of symptoms and providing support and resources to address emotional and existential concerns. This article reviews surgical and nonsurgical palliative treatments for the symptoms and complications associated with advanced, incurable peritoneal carcinomatosis. It is important that providers caring for patients with peritoneal carcinomatosis be knowledgeable in the palliative management of this condition, including the usefulness of early palliative care referral.

Keywords: Ascites; Carcinomatosis; Hospice; Obstruction; Palliative.

Publication types

Review

MeSH terms

Disease Management
Humans
Palliative Care*
Peritoneal Neoplasms / therapy*
Quality of Life*